Hypoglycemic and Hypolipemic effects of a new lecithin formulation of Bergamot Polyphenolic Fraction: a double blind, randomized, placebo-controlled study.
CONCLUSION: These data suggest that better absorption and tissue distribution of BPF Phyto formulation represents an innovative approach in supplementation treatments of cardiometabolic disorders.
PMID: 30501605 [PubMed - as supplied by publisher]
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Endocr Metab Immune Disord Drug Targets Source Type: research
More News: Bergamot | Cardiology | Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Gastroenterology | Heart | Lecithin | Statin Therapy | Study